MedTrace Logo

LaserACE® Procedure Restore Visual Function and Range of Accommodation LaserACE® Procedure

NCT01491360 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 8

Last updated 2021-10-27

No results posted yet for this study

Summary

A new minimally invasive procedure for treating presbyopia is being evaluated to determine if there is improvement in near and intermediate vision after treatment.

Conditions

Interventions

PROCEDURE

LaserACE(R)

Partial depth scleral micro-excisions with an Er:YAG laser in a predetermined pattern.

Sponsors & Collaborators

  • Vision Renu Taiwan Corporation

    collaborator INDUSTRY

  • ACE Vision Group, Inc.

    lead INDUSTRY

Principal Investigators

  • David Ma, MD · Chang Gung Memorial Hospital, Taipei, Taiwan

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-12-31
Primary Completion
2015-12-31
Completion
2016-01-31

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01491360 on ClinicalTrials.gov